Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

miRNA Profiling for Early Detection and Treatment of Duchenne Muscular Dystrophy
Heather Hrach, Marco Mangone
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 18, pp. 4638-4638
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

RNA-Based Therapeutics: From Antisense Oligonucleotides to miRNAs
Sarah Bajan, György Hutvàgner
Cells (2020) Vol. 9, Iss. 1, pp. 137-137
Open Access | Times Cited: 317
CRISPR-Cas12a enhanced rolling circle amplification method for ultrasensitive miRNA detection
Gong Zhang, Lei Zhang, Jingtao Tong, et al.
Microchemical Journal (2020) Vol. 158, pp. 105239-105239
Closed Access | Times Cited: 113
Biomarkers for Duchenne muscular dystrophy: myonecrosis, inflammation and oxidative stress
Miranda D. Grounds, Jessica R. Terrill, Basma A. Al-Mshhdani, et al.
Disease Models & Mechanisms (2020) Vol. 13, Iss. 2
Open Access | Times Cited: 107
Mitochondrial Dysfunction in Intensive Care Unit-Acquired Weakness and Critical Illness Myopathy: A Narrative Review
Felix Klawitter, Johannes Ehler, Rika Bajorat, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5516-5516
Open Access | Times Cited: 20
Complexity of skeletal muscle degeneration: multi-systems pathophysiology and organ crosstalk in dystrophinopathy
Kay Ohlendieck, Dieter Swandulla
Pflügers Archiv - European Journal of Physiology (2021) Vol. 473, Iss. 12, pp. 1813-1839
Open Access | Times Cited: 33
Therapeutic aspects of cell signaling and communication in Duchenne muscular dystrophy
Alicja Starosta, Patryk Konieczny
Cellular and Molecular Life Sciences (2021) Vol. 78, Iss. 11, pp. 4867-4891
Open Access | Times Cited: 27
Biomarkers in Duchenne Muscular Dystrophy: Current Status and Future Directions
F. Fortunato, Alessandra Ferlini
Journal of Neuromuscular Diseases (2023) Vol. 10, Iss. 6, pp. 987-1002
Open Access | Times Cited: 10
PAX7, a Key for Myogenesis Modulation in Muscular Dystrophies through Multiple Signaling Pathways: A Systematic Review
Nor Idayu A. Rahman, C Lam, Nadiah Sulaiman, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13051-13051
Open Access | Times Cited: 8
Molecular profiling of plasma-derived extracellular vesicle cargo in Duchenne muscular dystrophy using integration of FTIR spectroscopy and machine learning: Revealing disease signatures
Archana Rajavel, E. S. Narayanan, Ramajayam Anbazhagan, et al.
Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy (2024) Vol. 326, pp. 125236-125236
Closed Access | Times Cited: 3
Identification of Cardiomyopathy-Associated Circulating miRNA Biomarkers in Muscular Dystrophy Female Carriers Using a Complementary Cardiac Imaging and Plasma Profiling Approach
Anca Florian, Alexandru Patrascu, Roman Tremmel, et al.
Frontiers in Physiology (2018) Vol. 9
Open Access | Times Cited: 22
Longitudinal Study of Three microRNAs in Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
Selena Trifunov, Daniel Natera‐de Benito, J. Expósito, et al.
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 20
Epigenetics of neuromuscular disorders
Fabio Coppedè
Epigenomics (2020) Vol. 12, Iss. 23, pp. 2125-2139
Closed Access | Times Cited: 18
Duchenne Muscular Dystrophy: recent advances in protein biomarkers and the clinical application
Cristina Al‐Khalili Szigyarto
Expert Review of Proteomics (2020) Vol. 17, Iss. 5, pp. 365-375
Open Access | Times Cited: 17
New advancements in CRISPR based gene therapy of Duchenne muscular dystrophy
Atieh Eslahi, Farzaneh Alizadeh, Amir Avan, et al.
Gene (2023) Vol. 867, pp. 147358-147358
Closed Access | Times Cited: 6
MiRNAs, Myostatin, and Muscle MRI Imaging as Biomarkers of Clinical Features in Becker Muscular Dystrophy
Roberta Marozzo, Valentina Pegoraro, C. Angelini
Diagnostics (2020) Vol. 10, Iss. 9, pp. 713-713
Open Access | Times Cited: 13
Assessment of Weighted Gene Co-Expression Network Analysis to Explore Key Pathways and Novel Biomarkers in Muscular Dystrophy
Xiaoxue Xu, Yuehan Hao, Jiao Wu, et al.
Pharmacogenomics and Personalized Medicine (2021) Vol. Volume 14, pp. 431-444
Open Access | Times Cited: 10
Identification of circulating miRNAs differentially expressed in patients with Limb-girdle, Duchenne or facioscapulohumeral muscular dystrophies
José Luis García‐Gimenez, Elena R. García‐Trevijano, Ana Isabel Avilés‐Alía, et al.
Orphanet Journal of Rare Diseases (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 7
Differential responses to avian pathogenic E. coli and the regulatory role of splenic miRNAs in APEC infection in Silkie chickens
Wenqing Li, Wanli Li, Pinhui Wu, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 1
Comprehensive Analysis of Long Non-coding RNA-Associated Competing Endogenous RNA Network in Duchenne Muscular Dystrophy
Xiaoxue Xu, Yuehan Hao, Shuang Xiong, et al.
Interdisciplinary Sciences Computational Life Sciences (2020) Vol. 12, Iss. 4, pp. 447-460
Closed Access | Times Cited: 10
Does β-Hydroxy-β-Methylbutyrate Have Any Potential to Support the Treatment of Duchenne Muscular Dystrophy in Humans and Animals?
Abdolvahab Ebrahimpour Gorji, Piotr Ostaszewski, Kaja Urbańska, et al.
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2329-2329
Open Access | Times Cited: 2
Identification of hub genes, miRNAs and regulatory factors relevant for Duchenne muscular dystrophy by bioinformatics analysis
Mengxi Xiu, Bin Zeng, Bohai Kuang
International Journal of Neuroscience (2020) Vol. 132, Iss. 3, pp. 296-305
Closed Access | Times Cited: 5
miRNomic Signature in Very Low Birth-Weight Neonates Discriminates Late-Onset Gram-Positive Sepsis from Controls
Eva Serna, Anna Parra‐Llorca, Joaquín Panadero, et al.
Diagnostics (2021) Vol. 11, Iss. 8, pp. 1389-1389
Open Access | Times Cited: 5
Can Wharton jelly derived or adipose tissue derived mesenchymal stem cell can be a treatment option for duchenne muscular dystrophy? Answers as transcriptomic aspect.
Eda Sun, Erdal Karaöz
PubMed (2020) Vol. 9, Iss. 4, pp. 57-67
Closed Access | Times Cited: 4
The implications of cell‐free DNAs derived from tumor viruses as biomarkers of associated cancers
Yiwei Wang, Yanling Li, Xinyu Liang, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 10, pp. 4677-4688
Closed Access | Times Cited: 3
Progress in the Treatment of Duchenne Muscular Dystrophy
惠文 赵
Advances in Clinical Medicine (2024) Vol. 14, Iss. 04, pp. 2420-2426
Closed Access
Page 1 - Next Page

Scroll to top